Few studies have examined the effectiveness of these medications in stroke survivors as there is insufficient evidence to recommend the use of cholinesterase inhibitors, memantine nootropics, or cognitive rehabilitation for CD patients [7]. This evidence concerns the gene BCHE and Stroke.